[8-K] Surgery Partners, Inc. Reports Material Event

Rhea-AI Filing Summary

Surgery Partners, Inc. (SGRY) furnished an 8-K announcing results for the three and nine months ended September 30, 2025. The company issued a press release, attached as Exhibit 99.1, detailing the period’s performance.

The disclosure under Item 2.02 is provided pursuant to General Instruction B.2 and is deemed furnished, not filed. The release includes non-GAAP financial measures with reconciliations to the most comparable GAAP measures.

0001638833FALSE00016388332025-11-102025-11-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 10, 2025

Surgery Partners, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware			001-37576			47-3620923
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(IRS Employer Identification No.)

340 Seven Springs Way, Suite 600

Brentwood, Tennessee 37027

(Address of Principal Executive Offices) (Zip Code)

(615) 234-5900

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

SGRY

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On November 10, 2025, Surgery Partners, Inc. issued a press release announcing results for the three and nine months ended September 30, 2025. See the press release attached as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

Surgery Partners makes reference to non-GAAP financial measures in the attached press release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP financial measures is provided therein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

99.1						Press release dated November 10, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						SURGERY PARTNERS, INC.
Date:			November 10, 2025			By:			/s/ David T. Doherty
									David T. Doherty
									Executive Vice President and Chief Financial Officer

FAQ

What did Surgery Partners (SGRY) announce in this 8-K?

It furnished a press release announcing results for the three and nine months ended September 30, 2025 under Item 2.02.

Where can I find the detailed quarterly results for SGRY?

Details are in the press release attached as Exhibit 99.1.

Does the filing include non-GAAP metrics for SGRY?

Yes. The press release includes non-GAAP financial measures with reconciliations to comparable GAAP metrics.

Is the information considered filed with the SEC?

No. Under General Instruction B.2, the information, including Exhibit 99.1, is furnished and not filed.

Which period do the SGRY results cover?

They cover the three and nine months ended September 30, 2025.

What other exhibits accompany the 8-K?

Exhibits include 99.1 (press release) and 104 (Cover Page Inline XBRL data file).